# Protalix BioTherapeutics, Inc.: Form DEF 14A, filed Jul 1, 2016

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: DEF 14A
- Filed: 2016-07-01
- Accepted by EDGAR: Jul 1, 2016, 17:04 ET
- Period: 2016-08-07
- Accession: 0001144204-16-111273
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000114420416111273/v443094_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000114420416111273/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000114420416111273/v443094_def14a.htm

Filed Jul 1, 2016.
Source: SEC EDGAR, the filing index for accession 0001144204-16-111273. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
